DNA-Guided antidepressant choice may ease teen anxiety and depression
NCT ID NCT06853587
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study tests whether using a genetic test to guide antidepressant selection helps teens aged 12-17 with anxiety or depression feel better faster and with fewer side effects. About 452 teens will be randomly assigned to either gene-guided prescribing or standard care for 12 weeks. The goal is to see if personalized medicine can improve remission rates and reduce drug reactions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY AND DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Calgary
RECRUITINGCalgary, Alberta, T2N 4N1, Canada
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.